Introduction: rationale for tight control of hyperglycemia.
Cannon
Christopher P
CP
The Thrombolysis in Myocardial Infarction (TIMI) Study Group, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, 75 Francis Street, Boston, Massachusetts 02115, USA. cpcannon@partners.org
D001786:Blood Glucose; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000517:prevention & control*; D003930:Diabetic Retinopathy / Q000097:blood / Q000517:prevention & control*; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000517:prevention & control*; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic
D001786:Blood Glucose; D007004:Hypoglycemic Agents